Fundraising Fox

Irhythmtech

NASDAQ: IRTC

San Francisco, US · Founded 2006 · Delaware corporation · 1,905 employees on LinkedIn · 3 known investors

iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.

Founders & leadership

KM
Kevin M. KingExecutive
RR
Roberta R. KatzNamed on SEC filing
SD
Shelly D. GuyerNamed on SEC filing
WF
William F. WillisNamed on SEC filing
SE
Sam E. BraschNamed on SEC filing
RH
R. Hardwin MeadNamed on SEC filing
JL
Judith LenaneNamed on SEC filing
SJ
Steve JohnsonNamed on SEC filing

Board

TATiba Aynechi
Tiba AynechiinMember Board of Directors2014–2017General Partner at Norwest Venture Partners
JL
Joshua L. GreenBoard director
CDCasper de Clercq
Casper de Clercqin𝕏Board Director2013–2017General Partner at Norwest Venture Partners
CEChris E. Grant
Chris E. GrantinBoard directorCo-Founder & Chief Operating Officer and Executive Vice President, The Permanente Federation LLC at Kaiser Permanente Ventures

Investors · 3

Reported raises · per SEC filings

Form D private placements

$49.5M disclosed across 2 rounds · 2011–2014

$27.3MraisedMar 2015 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin M. KingExecutive Officer, Director
  • Tiba AynechiDirector
  • Joshua L. GreenDirector
  • Casper de ClercqDirector
  • Chris E. GrantDirector
  • William N. StarlingDirector
  • Raymond ScottDirector
  • Vijay K. LathiDirector
Offering amount
$29.5M
Amount sold
$27.3M
Minimum investment
$1
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$22.1MraisedJan 2012 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Roberta R. KatzDirector
  • Shelly D. GuyerExecutive Officer
  • William N. StarlingDirector
  • William F. WillisExecutive Officer, Director
  • Sam E. BraschDirector
  • Joshua L. GreenDirector
  • R. Hardwin MeadDirector
  • Judith LenaneExecutive Officer
  • Steve JohnsonExecutive Officer
  • Vijay K. LathiDirector
Offering amount
$22.1M
Amount sold
$22.1M
First sale
Apr 2011
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Irhythmtech for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Irhythmtech do?
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.
Who are Irhythmtech's investors?
Irhythmtech's investors include Kaiser Permanente Ventures, Norwest Venture Partners, New Leaf Venture Partners.
How much funding has Irhythmtech raised?
Irhythmtech has disclosed $49.5M raised across 2 rounds.
Where is Irhythmtech headquartered?
Irhythmtech is headquartered in San Francisco, US.